Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SCB101-DD
- Development stage
- Preclinical
- Lead developer
- Hainan Shuangcheng Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Injection
01
Overview
SCB101-DD is a long-acting formulation developed by Hainan Shuangcheng Pharmaceuticals. It is provided in vial form with strengths of 80 mg and 120 mg. While the specific active pharmaceutical ingredient and therapeutic indication are not explicitly detailed in the company's public product listings, the 'SCB' prefix is used by Shuangcheng for several of its long-acting injectable products, which often include peptide-based or hormonal therapies. The drug is currently part of Shuangcheng's product portfolio, though its specific clinical development phase for particular indications remains undisclosed in general pipeline summaries.
- Other names
- SCB101-DD (long-acting)SCB101-DD-Shuangcheng-long-acting formulationSCB-101-DD-Shuangcheng-long-acting formulationSCB 101-DD-Shuangcheng-long-acting formulation
Beyond the preview
Go deeper on SCB101-DD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCB101-DD.